# Blog # Blog Categories [Alzheimers Disease](/news-and-resources/blog/category/alzheimers-disease/) [Parkinsons Disease](/news-and-resources/blog/category/parkinsons-disease/) [PET](/news-and-resources/blog/category/pet/) [Bio-Hermes](/news-and-resources/blog/category/bio-hermes/) [Amyloid PET](/news-and-resources/blog/category/amyloid-pet/) [MRI](/news-and-resources/blog/category/mri/) [Multiple Sclerosis](/news-and-resources/blog/category/multiple-sclerosis/) [Review](/news-and-resources/blog/category/review/) [Partnerships](/news-and-resources/blog/category/partnerships/) Library [October 2026](/news-and-resources/blog/archive/2026/10/) [September 2026](/news-and-resources/blog/archive/2026/09/) [July 2026](/news-and-resources/blog/archive/2026/07/) [June 2026](/news-and-resources/blog/archive/2026/06/) [May 2026](/news-and-resources/blog/archive/2026/05/) [April 2026](/news-and-resources/blog/archive/2026/04/) [March 2026](/news-and-resources/blog/archive/2026/03/) [February 2026](/news-and-resources/blog/archive/2026/02/) [January 2026](/news-and-resources/blog/archive/2026/01/) [2025](/news-and-resources/blog/archive/2025/) [2024](/news-and-resources/blog/archive/2024/) [2023](/news-and-resources/blog/archive/2023/) [2022](/news-and-resources/blog/archive/2022/) [2021](/news-and-resources/blog/archive/2021/) [2020](/news-and-resources/blog/archive/2020/) [2019](/news-and-resources/blog/archive/2019/) [ Categories ](javascript:void(0);) [Alzheimers Disease](/news-and-resources/blog/category/alzheimers-disease/) [Parkinsons Disease](/news-and-resources/blog/category/parkinsons-disease/) [PET](/news-and-resources/blog/category/pet/) [Bio-Hermes](/news-and-resources/blog/category/bio-hermes/) [Amyloid PET](/news-and-resources/blog/category/amyloid-pet/) [MRI](/news-and-resources/blog/category/mri/) [Multiple Sclerosis](/news-and-resources/blog/category/multiple-sclerosis/) [Review](/news-and-resources/blog/category/review/) [Partnerships](/news-and-resources/blog/category/partnerships/) [ Library ](javascript:void(0);) [October 2026](/news-and-resources/blog/archive/2026/10/) [September 2026](/news-and-resources/blog/archive/2026/09/) [July 2026](/news-and-resources/blog/archive/2026/07/) [June 2026](/news-and-resources/blog/archive/2026/06/) [May 2026](/news-and-resources/blog/archive/2026/05/) [April 2026](/news-and-resources/blog/archive/2026/04/) [March 2026](/news-and-resources/blog/archive/2026/03/) [February 2026](/news-and-resources/blog/archive/2026/02/) [January 2026](/news-and-resources/blog/archive/2026/01/) [2025](/news-and-resources/blog/archive/2025/) [2024](/news-and-resources/blog/archive/2024/) [2023](/news-and-resources/blog/archive/2023/) [2022](/news-and-resources/blog/archive/2022/) [2021](/news-and-resources/blog/archive/2021/) [2020](/news-and-resources/blog/archive/2020/) [2019](/news-and-resources/blog/archive/2019/) [ ![Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/assets/blog-images/Alzheimers-biomarkers__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) 29 Sep 26 blog [ Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials ](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) [ Read more ](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) [ ![White matter hyperintensities: A precision neurology tool for Alzheimer’s patient stratification and improved trial sensitivity? ](/assets/blog-images/WMH-blog-title__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) 13 Jul 26 blog [ White Matter Hyperintensities: A precision neurology tool ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) [ Read more ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) [ ![Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease](/assets/blog-images/Neuromelanin-Blog__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) 4 Jun 26 blog [ Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease ](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) [ Read more ](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) [ ![From Information to Intelligence: New Platform Identity Explained](/assets/blog-images/Advancing-a-Multimodal-Future-for-Alzheimers-Disease-Diagnosis-3__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/) 20 Apr 26 blog [ From Information to Intelligence: New Platform Identity Explained ](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/) [ Read more ](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/) [ ![Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows](/assets/blog-images/Advancing-a-Multimodal-Future-for-Alzheimers-Disease-Diagnosis__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/) 12 Mar 26 blog [ Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows ](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/) [ Read more ](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/) [ ![Advancing a Multimodal Future for Alzheimer’s Disease Diagnosis](/assets/blog-images/Advancing-a-Multimodal-Future-for-Alzheimers-Disease-Diagnosis__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/advancing-a-multimodal-future-for-alzheimers-disease-diagnosis/) 17 Feb 26 blog [ Advancing a Multimodal Future for Alzheimer’s Disease Diagnosis ](/news-and-resources/blog/advancing-a-multimodal-future-for-alzheimers-disease-diagnosis/) [ Read more ](/news-and-resources/blog/advancing-a-multimodal-future-for-alzheimers-disease-diagnosis/) [ ![Multi-biomarker assessment to better understand clinical dementia symptoms](/assets/blog-images/Multi-biomarker-assessment-to-better-understand-clinical-dementia-symptoms__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/multi-biomarker-assessment-to-better-understand-clinical-dementia-symptoms/) 17 Feb 26 blog [ Multi-biomarker assessment to better understand clinical dementia symptoms ](/news-and-resources/blog/multi-biomarker-assessment-to-better-understand-clinical-dementia-symptoms/) [ Read more ](/news-and-resources/blog/multi-biomarker-assessment-to-better-understand-clinical-dementia-symptoms/) [ ![Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics](/assets/blog-images/Advancing-Amyloid-Assessment-in-PET-Imaging-Integrating-AI-with-Quantitative-Metrics__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/advancing-amyloid-assessment-in-pet-imaging-integrating-ai-with-quantitative-metrics/) 13 Jan 26 blog [ Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics ](/news-and-resources/blog/advancing-amyloid-assessment-in-pet-imaging-integrating-ai-with-quantitative-metrics/) [ Read more ](/news-and-resources/blog/advancing-amyloid-assessment-in-pet-imaging-integrating-ai-with-quantitative-metrics/) [ ![Exploring how GLP-1 Drugs and vascular biomarkers are shaping Alzheimer’s Disease clinical trial design](/assets/blog-images/Exploring-how-GLP-1-Drugs-and-vascular-biomarkers-are-shaping-Alzheimers-Disease-clinical-trial-design-1__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/exploring-how-glp-1-drugs-and-vascular-biomarkers-are-shaping-alzheimers-disease-clinical-trial-design/) 28 Nov 25 blog [ Exploring how GLP-1 Drugs and vascular biomarkers are shaping AD clinical trial design ](/news-and-resources/blog/exploring-how-glp-1-drugs-and-vascular-biomarkers-are-shaping-alzheimers-disease-clinical-trial-design/) [ Read more ](/news-and-resources/blog/exploring-how-glp-1-drugs-and-vascular-biomarkers-are-shaping-alzheimers-disease-clinical-trial-design/) [ ![The Emergence of Neuromelanin-Sensitive Imaging in Parkinson’s Disease Clinical Trials](/assets/blog-images/The-Emergence-of-Neuromelanin-Sensitive-Imaging-in-Parkinsons-Clinical-Trials-N-1__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/the-emergence-of-neuromelanin-sensitive-imaging-in-parkinsons-clinical-trials/) 26 Nov 25 blog [ The Emergence of Neuromelanin-Sensitive Imaging in Parkinson’s Disease Clinical Trials ](/news-and-resources/blog/the-emergence-of-neuromelanin-sensitive-imaging-in-parkinsons-clinical-trials/) [ Read more ](/news-and-resources/blog/the-emergence-of-neuromelanin-sensitive-imaging-in-parkinsons-clinical-trials/) [ ![Advancing AD Trials: Integrating Plasma Biomarkers and Imaging for Precision Enrolment](/assets/blog-images/Advancing-AD-Trials-Integrating-Plasma-Biomarkers-and-Imaging-for-Precision-Enrolment-1__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/advancing-ad-trials-integrating-plasma-biomarkers-and-imaging-for-precision-enrolment/) 23 Oct 25 blog [ Advancing AD Trials: Integrating Plasma Biomarkers and Imaging for Precision Enrolment ](/news-and-resources/blog/advancing-ad-trials-integrating-plasma-biomarkers-and-imaging-for-precision-enrolment/) [ Read more ](/news-and-resources/blog/advancing-ad-trials-integrating-plasma-biomarkers-and-imaging-for-precision-enrolment/) [ ![A Quick Guide to Imaging Analysis & Operations Essentials in Parkinson’s Disease Clinical Research](/assets/blog-images/A-Quick-Guide-to-Imaging-Analysis-Operations-Essentials-in-Parkinsons-Disease-Clinical-Research-n__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/a-quick-guide-to-imaging-analysis-and-operations-essentials-in-parkinsons-disease-clinical-research/) 13 Oct 25 blog [ A Quick Guide to Imaging Analysis & Operations Essentials in Parkinson’s Disease Clinical Research ](/news-and-resources/blog/a-quick-guide-to-imaging-analysis-and-operations-essentials-in-parkinsons-disease-clinical-research/) [ Read more ](/news-and-resources/blog/a-quick-guide-to-imaging-analysis-and-operations-essentials-in-parkinsons-disease-clinical-research/) [1](javascript:void(0);) [2](/news-and-resources/blog/index.md?start=12) [3](/news-and-resources/blog/index.md?start=24) [Prev](javascript:void(0);) [Next](/news-and-resources/blog/index.md?start=12) 1 - 12 of 35 results ## Sign-up to the latest from IXICO